INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

1,095 studies · page 5 of 46

2022 / Meta-analysis of prospective studies

Higher soy isoflavone consumption was linked to lower breast cancer occurrence in both pre- and post-menopausal women.

A systematic review and meta-analysis evaluated the relationship between the amount of soy and isoflavone consumption and breast cancer risk using data gathered according to PRISMA guidelines. Statistical analysis of prospective studies demonstrated significant results, with data showing a clear inverse correlation between the amount of isoflavones consumed and breast cancer occurrence in pre- and post-menopausal women.

Shows an association, not proof of cause and effect.

Boutas I, Kontogeorgi A, Dimitrakakis C, et al. In Vivo, 2022. PMID 35241506

2022 / Meta-analysis of clinical studies

NAD+ precursor supplementation improved lipid profiles but raised blood glucose levels in humans.

A meta-analysis of 40 articles (14,750 cases) evaluated the effects of NAD+ precursors (NR, NMN, NA, and NAM) on lipid and glucose metabolism. NAD+ precursor supplementation significantly reduced TG (SMD = -0.35, P < 0.0001), TC (SMD = -0.33, P = 0.0005), and LDL (SMD = -0.38, P < 0.00001), while increasing HDL (SMD = 0.66, P < 0.00001) and plasma glucose (SMD = 0.27, P = 0.0004). Subgroup analyses indicated nicotinic acid (NA) had the most significant effects on these markers, with significant benefits seen in patients with cardiovascular disease and dyslipidemia but little effect in healthy people. The authors note the conclusions are limited by the number and quality of included studies.

Zhong O, Wang J, Tan Y, et al. Nutr Metab (Lond), 2022. PMID 35303905

2022 / Systematic review and dose-response meta-analysis of RCTs

Chlorella vulgaris supplementation reduced total cholesterol and LDL-C levels in adults, without significantly affecting triglycerides or HDL-C.

A systematic review and meta-analysis of 10 randomized controlled trials evaluated the effects of Chlorella vulgaris supplementation on lipid profiles in 539 adults. Supplementation led to significant reductions in total cholesterol (MD -7.47 mg/dL, 95% CI: -12.98 to -1.96) and LDL-C (MD -7.71 mg/dL, 95% CI: -14.05 to -1.37), but had no significant effect on triglycerides (MD -2.11 mg/dL, 95% CI: -7.28 to 3.06) or HDL-C (MD -0.45 mg/dL, 95% CI: -0.67 to 1.57). Dose-response analysis revealed the LDL-C-reducing effect occurred at dosages between 0 and 1500 mg/d (P for non-linearity = 0.01), with no significant effect at higher amounts. Only four of the 10 trials had low risk of bias across all Cochrane domains, and only two verified the content, purity, potency, and contamination of the supplements.

Sherafati N, Bideshki MV, Behzadi M, et al. Complement Ther Med, 2022. PMID 35331862

2022 / Systematic review and meta-analysis of randomized clinical trials

GLP-1 receptor agonist use was linked to increased risks of gallbladder and biliary diseases in a meta-analysis of randomized clinical trials.

A systematic review and meta-analysis of 76 RCTs with 103,371 patients examined the risk of gallbladder or biliary diseases associated with GLP-1 receptor agonists compared to placebo or non-GLP-1 RA drugs. Randomization to GLP-1 RA treatment was associated with increased risk of gallbladder or biliary diseases (RR 1.37; 95% CI, 1.23-1.52), including cholelithiasis (RR 1.27; 95% CI, 1.10-1.47), cholecystitis (RR 1.36; 95% CI, 1.14-1.62), and biliary disease (RR 1.55; 95% CI, 1.08-2.22). Risks were higher in trials for weight loss (RR 2.29; 95% CI, 1.64-3.18) than for type 2 diabetes or other diseases (RR 1.27; 95% CI, 1.14-1.43), as well as with higher doses (RR 1.56 vs 0.99 for lower doses) and longer durations of use (RR 1.40 vs 0.79 for shorter duration).

He L, Wang J, Ping F, et al. JAMA Intern Med, 2022. PMID 35344001

2022 / Systematic review and dose-response meta-analysis of cohort studies

In a meta-analysis of cohort studies, highest versus lowest egg consumption was linked to a higher risk of cancer mortality, but not all-cause or CVD mortality.

Researchers conducted a systematic review and dose-response meta-analysis of 33 cohort studies including 2,216,720 participants and 232,408 all-cause deaths to evaluate egg intake and mortality risk. Comparing the highest versus lowest egg intake categories showed no association with all-cause mortality (RR: 1.02; 95% CI: 0.94, 1.11), CVD (RR: 1.04; 95% CI: 0.87, 1.23), CHD (RR: 0.98; 95% CI: 0.84, 1.16), stroke (RR: 0.81; 95% CI: 0.64, 1.02), or respiratory disease mortality (RR: 0.96; 95% CI: 0.53, 1.71), but was associated with higher cancer mortality (RR: 1.20; 95% CI: 1.04, 1.39). In linear dose-response analyses, each additional egg per week was linked to a 2% and 4% increased risk of all-cause and cancer mortality, respectively, and a 4% decreased risk of stroke mortality. The certainty of the evidence was rated as low to moderate.

Shows an association, not proof of cause and effect.

Mousavi SM, Zargarzadeh N, Rigi S, et al. Adv Nutr, 2022. PMID 35396834

2022 / Systematic review of prospective controlled and uncontrolled trials

Lifestyle modifications and PPIs show effectiveness for treating nocturnal gastroesophageal reflux symptoms.

A systematic review of 31 prospective clinical trials evaluated interventions for nocturnal gastroesophageal reflux symptoms in adults. Lifestyle studies evaluated head of bed elevation (n=5), prolonging dinner-to-bed time (n=2), and promoting left lateral decubitus position (n=2). Placebo-controlled trials of proton pump inhibitors (n=11) demonstrated success rates ranging from 34.4% to 80.8% with PPIs versus 10.4% to 51.7% with placebo. Authors concluded that a sequential strategy of head of bed elevation, prolonging dinner-to-bed time, promoting left lateral decubitus position, and acid-suppressive medication is recommended, whereas evidence remains insufficient for nCPAP, hypnotics, baclofen, and bedtime H2 receptor antagonists.

Schuitenmaker JM, Kuipers T, Smout AJPM, et al. Neurogastroenterol Motil, 2022. PMID 35445777

2022 / Systematic review and dose-response meta-analysis

Higher egg consumption was linked to a modestly increased risk of all-cause mortality, especially in certain subgroups.

Researchers conducted a meta-analysis of 24 articles with 48 reports (11,890,695 participants) to examine egg intake and mortality risks. Each 1-egg/day increase was associated with a higher risk of all-cause mortality (RR: 1.06; 95% CI: 1.02, 1.10; P = 0.008), though this was restricted to women, Americans, and studies adjusting for hyperlipidemia. A linear association with CVD mortality appeared only in adults >60 years, Americans, studies with ≥15 years follow-up, and those adjusting for hyperlipidemia (P ≤ 0.018). No significant associations were observed for ischemic heart disease or stroke mortality (P ≥ 0.080).

Shows an association, not proof of cause and effect.

Ma W, Zhang Y, Pan L, et al. J Nutr, 2022. PMID 35524693

2022 / Systematic review and meta-analysis

Voluntary slow breathing increases vagally-mediated heart rate variability during, immediately after, and following multi-session interventions.

A systematic review and meta-analysis evaluated the effects of voluntary slow breathing (VSB) on heart rate variability (HRV) parameters indexing parasympathetic nervous system activity regulating cardiac functioning (vmHRV). From 1,842 selected abstracts, 223 studies were included (172 assessing effects during the session, 16 immediately after one session, and 49 after a multi-session intervention). Results showed increases in vmHRV during VSB, immediately after one session, and after a multi-session intervention.

Laborde S, Allen MS, Borges U, et al. Neurosci Biobehav Rev, 2022. PMID 35623448

2022 / Meta-analysis of randomized controlled trials

Daily vitamin D supplementation reduced cancer mortality overall and cancer incidence specifically in normal-weight individuals.

A meta-analysis evaluated RCTs to assess whether vitamin D dosing strategies and adiposity affect total cancer outcomes. Across 12 trials, vitamin D supplementation did not reduce total cancer incidence overall (SRR 0.99, 95% CI 0.94-1.03), though daily dosing showed an inverse association among normal-weight individuals (SRR 0.76, 95% CI 0.64-0.90) but not overweight/obese participants. For total cancer mortality (6 trials), the overall SRR was 0.92 (95% CI 0.82-1.03), but daily supplementation significantly reduced mortality (SRR 0.87, 95% CI 0.78-0.96) while infrequent large-bolus dosing did not.

Keum N, Chen QY, Lee DH, et al. Br J Cancer, 2022. PMID 35676320

2022 / Systematic review and dose-response meta-analysis

Higher egg and dietary cholesterol intakes were linked to increased risks of all-cause and cancer mortality in a meta-analysis of prospective cohort studies.

A meta-analysis of 55 prospective cohort studies evaluated the relationship between egg and dietary cholesterol intake and mortality. Each additional egg per day was associated with a 7% higher risk of all-cause mortality (RR 1.07, 95% CI: 1.02-1.12) and a 13% higher risk of cancer mortality (RR 1.13, 95% CI: 1.06-1.20), but not CVD mortality (RR 1.00, 95% CI: 0.92-1.09). Each 100 mg/day increment of dietary cholesterol was linked to a 6% higher risk of all-cause mortality (RR 1.06, 95% CI: 1.03-1.08) and cancer mortality (RR 1.06, 95% CI: 1.05-1.07), but not CVD mortality. Little evidence for elevated risks appeared below 0.5 egg/day or 250 mg/day of cholesterol; the authors note findings should be considered with caution due to small risk estimates and moderate between-study heterogeneity.

Shows an association, not proof of cause and effect.

Darooghegi Mofrad M, Naghshi S, Lotfi K, et al. Front Nutr, 2022. PMID 35711545

2022 / Systematic review and meta-analysis of randomized controlled trials

Taurine supplementation significantly reduced HbA1c, fasting blood sugar, and HOMA-IR in patients with diabetes.

A meta-analysis of 5 randomized controlled trials (N = 209 participants) evaluated the effects of taurine supplementation in patients with diabetes. Compared with controls, taurine significantly reduced HbA1c (SMD -0.41 [95% CI: -0.74, -0.09], p = 0.01), fasting blood sugar (SMD -1.28 [95% CI: -2.42, -0.14], p = 0.03), and HOMA-IR (SMD -0.64 [95% CI: -1.22, -0.06], p = 0.03). Reductions in insulin (SMD -0.48 [95% CI: -0.99, 0.03], p = 0.06) and triglycerides (SMD -0.26 [95% CI: -0.55, 0.02], p = 0.07) did not reach statistical significance, and no significant effects were found for serum lipids, blood pressure, or body composition.

Tao X, Zhang Z, Yang Z, et al. Food Chem (Oxf), 2022. PMID 35769396

2022 / Systematic review of trials

A systematic review found unclear evidence for collagen supplementation in osteoarthritis and rheumatoid arthritis due to poor study quality and adverse effects.

A systematic review of 19 articles evaluated the effects of collagen supplementation in patients with osteoarthritis (OA, n = 9) and rheumatoid arthritis (RA, n = 10). OA studies used intact (n = 4) and hydrolyzed (n = 5) collagen, while all RA studies used intact type II collagen. Several included studies reported high adverse effects and low efficiency of collagen compared to routine treatments. Because risk of bias assessment indicated most studies were of poor quality, definitive conclusions regarding beneficial or detrimental effects could not be made.

Jabbari M, Barati M, Khodaei M, et al. Int J Rheum Dis, 2022. PMID 35791039

2022 / Systematic review and meta-analysis of observational studies

Ultra-processed food intake was linked to higher odds of depressive and anxiety symptoms and increased risk of subsequent depression.

A systematic review and meta-analysis examined 17 observational studies (15 cross-sectional, 2 prospective) with 385,541 participants to assess the relationship between ultra-processed food consumption and mental disorders. Greater intake was cross-sectionally associated with increased odds of common mental disorder symptoms (OR 1.53, 95% CI 1.43 to 1.63), depressive symptoms (OR 1.44, 95% CI 1.14 to 1.82), and anxiety symptoms (OR 1.48, 95% CI 1.37 to 1.59). In prospective studies, higher intake was associated with an increased risk of subsequent depression (HR 1.22, 95% CI 1.16 to 1.28). The authors noted that further rigorously designed prospective and experimental studies are needed to clarify causal pathways.

Shows an association, not proof of cause and effect.

Lane MM, Gamage E, Travica N, et al. Nutrients, 2022. PMID 35807749

2022 / Systematic review and meta-analysis of RCTs

Isolated soluble dietary fibre supplementation for at least 12 weeks significantly reduced body weight in overweight and obese individuals.

A systematic review and meta-analysis of randomised controlled trials evaluated isolated soluble dietary fibre supplementation for at least 12 weeks in overweight and obese patients. Compared with controls, participants receiving fibre supplementation showed a significantly higher reduction in body weight (MD -1.25 kg, 95% CI -2.24, -0.25; 27 RCTs; 1428 participants). Fibre supplementation was also accompanied by significant decreases in BMI, waist circumference, fasting blood insulin, and HOMA-IR.

Huwiler VV, Schönenberger KA, Segesser von Brunegg A, et al. Nutrients, 2022. PMID 35807808

2022 / Systematic review of randomized controlled trials

Dietary interventions combining increased iron supply with vitamin C were consistently effective for iron-deficiency anemia in women.

A systematic review of 14 randomized controlled trials evaluated dietary interventions aimed at increasing iron supply and/or its absorption (via vitamin C, vitamin D, or decreased phytate intake) in women of childbearing age with iron-deficiency anemia. The majority of studies supported dietary interventions, with interventions proving ineffective in only three studies. Interventions combining increased iron supply with increased vitamin C intake were confirmed effective across all reporting studies. Most included studies had a medium risk of bias, while four presented a high overall risk.

Skolmowska D, Głąbska D, Kołota A, et al. Nutrients, 2022. PMID 35807904

2022 / Random effects network meta-analysis of randomized trials

Bergamot and red yeast rice were the most effective nutraceuticals for reducing LDL-C and total cholesterol in a network meta-analysis of 131 trials.

A network meta-analysis assessed the comparative efficacy of various lipid-lowering nutraceuticals across 131 trials with 13,062 participants. Except for policosanols, all evaluated nutraceuticals reduced LDL-C (-1.21 to -0.17 mmol/l) and TC (-1.75 to -0.18 mmol/l) compared with placebo or no intervention. Bergamot and red yeast rice were the most effective for lowering LDL-C (-1.21 mmol/l [-46.8 mg/dl] and -0.94 mmol/l [-36.4 mg/dl], respectively) and TC. The authors noted that evidence for bergamot was based on a relatively small study group and requires further investigation.

Osadnik T, Goławski M, Lewandowski P, et al. Pharmacol Res, 2022. PMID 35988871

2022 / Umbrella review of systematic reviews and meta-analyses

Nut intake of 28 g/day was linked to lower risks of cardiovascular disease, cancer deaths, and all-cause mortality in an umbrella review.

An umbrella review analyzed 89 articles on nut and seed consumption and health outcomes, including 23 meta-analyses on disease and mortality and 66 on biomarkers. Eating 28 g/d of nuts compared with not eating nuts was associated with a 21% relative risk reduction in cardiovascular disease, an 11% reduction in cancer deaths, and a 22% reduction in all-cause mortality. Nut intake was also inversely associated with mortality from respiratory diseases, infectious diseases, and diabetes, though associations with diabetes incidence were mixed. Allergy and adverse reactions were reported in 1-2% of adult populations with substantial heterogeneity.

Shows an association, not proof of cause and effect.

Balakrishna R, Bjørnerud T, Bemanian M, et al. Adv Nutr, 2022. PMID 36041171

2022 / Systematic review of observational and intervention studies

A systematic review found conflicting evidence regarding the association between vegetarian or vegan diets and depression in adults.

Researchers systematically reviewed 23 studies (18 cross-sectional, three prospective cohort, and two randomized controlled trials) with 25 outcomes examining associations between vegetarian or vegan diets and depression in adults. Eleven (44%) outcomes indicated these diets were linked to higher rates of depression, seven (28%) showed beneficial effects, and seven (28%) found no association overall. Study quality was rated as good for four studies and fair for the remaining 19. Authors concluded that evidence on the relationship is contradictory, possibly due to study heterogeneity.

Shows an association, not proof of cause and effect.

Jain R, Larsuphrom P, Degremont A, et al. Nutr Bull, 2022. PMID 36045075

2022 / Umbrella meta-analysis of clinical trials

An umbrella meta-analysis found curcumin supplementation reduced TC, TG, and LDL-C and increased HDL-C in adults.

An umbrella meta-analysis of 19 articles evaluated the effect of curcumin supplementation on lipid profile parameters in adults using a random-effects model. Curcumin supplementation was effective in reducing total cholesterol (ES = -0.81 mg/dl; 95% CI: 1.39, -0.24, p = 0.006), triglycerides (ES: 0.84 mg/dl, 95% CI: 1.42, -0.27, p = 0.004), and LDL-C (ES: 0.49 mg/dl, 95% CI: 0.85, -0.13, p = 0.007). In addition, curcumin intake significantly increased HDL-C levels (ES: 1.34 mg/dl, 95% CI: 0.37, 2.31, p = 0.007).

Musazadeh V, Roshanravan N, Mohammadizadeh M, et al. Nutr Metab Cardiovasc Dis, 2022. PMID 36058763

2022 / Systematic review

Postdiagnosis intake of various plant-based foods was linked to improved prognosis in cancer survivors.

This systematic review summarized the association between postdiagnosis plant-based diets and prognosis in cancer survivors. A higher intake of plant-based foods was associated with improved prognosis. Specifically, better prognosis was noted with high intake of whole grains and fibre in colorectal cancer survivors, higher intake of fruit, vegetable, and fibre along with moderate soy/isoflavone intake in breast cancer survivors, and higher vegetable fat intake in prostate cancer survivors. The authors noted high heterogeneity between studies and emphasized the need for further research considering clinical factors and methodological aspects.

Shows an association, not proof of cause and effect.

Hardt L, Mahamat-Saleh Y, Aune D, et al. Curr Nutr Rep, 2022. PMID 36138327

2022 / Systematic review and meta-analysis

High intake of vegetarian and low-animal diets was linked to lower risks of total, hemorrhagic, and ischemic stroke.

A systematic review and meta-analysis of 17 studies evaluated stroke risk across vegetarian, low-animal, and high-animal diets over an average follow-up of 11.7 years. Compared to low use, high use of vegetarian and low-animal diets was associated with lower risks of hemorrhagic stroke (RR: 0.71 and 0.82), ischemic stroke (RR: 0.78 and 0.70), and total stroke (RR: 0.84 and 0.72), respectively. High use of a high-animal diet was associated with a relatively higher risk of stroke (RR: 1.12 [95% CI: 0.94, 1.29]). Among vegetarians, high fruit intake relative to high vegetable intake was linked to a lower stroke risk.

Shows an association, not proof of cause and effect.

Liu Y, Zhu L, Li D, et al. Asia Pac J Clin Nutr, 2022. PMID 36173214

2022 / Systematic review and meta-analysis

High-fructose corn syrup increased CRP compared to sucrose, but showed no significant differences in anthropometric or other metabolic parameters.

A systematic review and meta-analysis evaluated the effects of high-fructose corn syrup (HFCS) versus sucrose across 4 articles with 767 participants, where sweetener usage averaged 19% of daily caloric intake. Compared to sucrose, HFCS intake did not significantly change weight (WMD: -0.29 kg, 95% CI: -1.34 to 0.77, I2 = 0%), waist circumference, BMI, fat mass, TC, HDL, LDL, TG, SBP, or DBP. However, data from three studies showed a significant increase in CRP levels in the HFCS group compared to sucrose (WMD: 0.27 mg/l, 95% CI: 0.02 to 0.52, I2 = 23%).

Li X, Luan Y, Li Y, et al. Front Nutr, 2022. PMID 36238453

2022 / Systematic review and DALY benefit-risk analysis

Coffee consumption was linked to an inverse relationship with all-cause mortality, potentially preventing healthy years of life lost.

Researchers conducted a systematic review and appraisal of meta-analyses to evaluate the benefit-risk of coffee consumption on all-cause mortality using the BRAFO framework and DALYs. Meta-analyses consistently reported an inverse relationship between coffee consumption and all-cause mortality. Consuming one cup of coffee per day was estimated to prevent more than 3.5 million DALYs (~3.35% of estimated years of healthy life lost), while current consumption rates (1 to 8 cups/day) could prevent up to 4.7% of lost years, and drinking 3 cups per day could prevent an estimated 6% of years of healthy life lost.

Shows an association, not proof of cause and effect.

Doepker C, Movva N, Cohen SS, et al. Food Chem Toxicol, 2022. PMID 36243217

2022 / Systematic review and meta-analysis of randomized controlled trials

Oral bergamot supplementation significantly improved serum total cholesterol, triglycerides, LDL-C, and HDL-C levels in adults.

A systematic review and meta-analysis of 14 randomized controlled trials evaluated the effects of oral bergamot supplementation on adult lipid profiles using a random-effects model. Bergamot supplementation significantly reduced total cholesterol (WMD: -63.60 mg/dL; 95% CI: -78.03 to -49.18; p < .001), triglycerides (WMD: -74.72 mg/dL; 95% CI: -83.58 to -65.87; p < .001), and LDL-C (WMD: -55.43 mg/dL; 95% CI: -67.26 to -43.60; p < .001), while significantly increasing HDL-C (WMD: 5.78 mg/dL; 95% CI: 3.27 to 8.28; p < .001). However, findings regarding nutraceuticals containing bergamot were inconsistent, and the authors noted that higher-quality studies are needed to further establish clinical efficacy.

Sadeghi-Dehsahraei H, Esmaeili Gouvarchin Ghaleh H, Mirnejad R, et al. Phytother Res, 2022. PMID 36251526